Protons, the positively charged particles that help build every atom in our bodies, are starting to look less like classical ...

There are “costs of life” that mechanical physics cannot calculate. A clear example is the energy required to keep specific ...

Two related discoveries detailing nanocrystalline mineral formation and dynamics have broad implications for managing nuclear ...

ArriVent BioPharma's furmonertinib demonstrates robust efficacy, CNS penetration, and tolerability in early trials. Read why ...

New travel experiences across Washington D.C. focus on history, public spaces, museums, rail travel, and cultural ...

Harkness Memorial State Park is undoubtedly one of the prettiest state parks in Connecticut. Boasting views of the Long ...

Research reveals how natural selection shaped the Bajau sea nomads’ spleens to boost oxygen delivery, helping them dive for ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

The U.S. Food and Drug Administration (FDA) on Wednesday approved Omeros Corporation (NASDAQ: OMER) Yartemlea ...

Omeros on Wednesday said the approval covers Yartemlea for patients ages 2 and older with hematopoietic stem-cell transplant-associated thrombotic microangiopathy, a complication driven by the ...

YARTEMLEA is approved by the U.S. FDA for the treatment of TA-TMA in adults and in children ages two years and older. A marketing authorization application for YARTEMLEA for TA-TMA is under review by ...